
CCG 50014
CAS No. 883050-24-6
CCG 50014( CCG-50014 | CCG 50014 | CCG50014 )
Catalog No. M17641 CAS No. 883050-24-6
CCG 50014 is a potent and selective inhibitor of RGS4 with IC50 of 30 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 32 | Get Quote |
![]() ![]() |
5MG | 49 | Get Quote |
![]() ![]() |
10MG | 88 | Get Quote |
![]() ![]() |
25MG | 188 | Get Quote |
![]() ![]() |
50MG | 340 | Get Quote |
![]() ![]() |
100MG | 506 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameCCG 50014
-
NoteResearch use only, not for human use.
-
Brief DescriptionCCG 50014 is a potent and selective inhibitor of RGS4 with IC50 of 30 nM.
-
DescriptionCCG-50014 is a potent small molecule inhibitor of regulator of G-protein signaling protein 4 (RGS4).
-
In Vitro——
-
In VivoCCG50014 (10, 30, or 100 nM) attenuates the nociceptive responses during the late phase in a dose-dependent manner.
-
SynonymsCCG-50014 | CCG 50014 | CCG50014
-
PathwayOthers
-
TargetOther Targets
-
RecptorRGS16| RGS19| RGS4| RGS8
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number883050-24-6
-
Formula Weight316.35
-
Molecular FormulaC16H13FN2O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 62.5 mg/mL (197.57 mM)
-
SMILESCC1=CC=C(C=C1)N1SC(=O)N(CC2=CC=C(F)C=C2)C1=O
-
Chemical Name4-[(4-fluorophenyl)methyl]-2-(4-methylphenyl)-1,2,4-thiadiazolidine-3,5-dione
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Blazer LL, et al. Biochemistry, 2011, 50(15), 3181-3192.
molnova catalog



related products
-
Bromosporine
Bromosporine is a broad spectrum inhibitor for bromodomains for BRD2/4/9 and CECR2 (IC50: 0.41/0.29/0.122/0.017 μM), respectively.
-
Sergliflozin etabona...
Sergliflozin etabonate, a SGLT-2 inhibitor, is used potentially for the treatment of type 2 diabetes and obesity.
-
Anti-inflammatory ag...
Anti-inflammatory agent 49 is a potent inhibitor of Drp1-Fis1 interaction, inhibits GTPase, and can be used in the study of diseases caused by mitochondrial dysfunction.